The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders

American Journal of Clinical Pathology

Volumn 134, Issue 5, 2010, Pages 749-761

  Harrington, Alexandra ^a   Olteanu, Horatiu ^a   Kroft, Steven ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Blasts; Flow cytometry; Immunophenotype; Myelodysplastic syndromes; Myeloproliferative neoplasms

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; BONE MARROW CELL; FACTUAL DATABASE; IMMUNOLOGY; KARYOTYPING; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BONE MARROW CELLS; DATABASES, FACTUAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; RETROSPECTIVE STUDIES;

EID: 78049510026     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPFNF5MN1GDWKU     Document Type: Article

References (28)

1. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98:979-987.
2. Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood. 2003;102:394-403. (Pubitemid 36759682)
3. Kussick SJ, Fromm JR, Rossini A, et al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol. 2005;124:170-181. (Pubitemid 41060126)
4. Ogata K, Kishikawa Y, Satoh C, et al. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood. 2006;108:1037-1044. (Pubitemid 44154642)
5. Truong F, Smith BR, Stachurski D, et al. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study. Leuk Res. 2009;33:1039-1046.
6. Stachurski D, Smith BR, Pozdnyakova O, et al. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res. 2007;32:215-224.
7. van de Loosdrecht AA, Westers TM, Westra AH, et al. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood. 2008;111:1067-1077.
8. Ogata K, Nakamura K, Yokose N, et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood. 2002;100:3887-3896.
9. Elghetany MT. Surface marker abnormalities in myelodysplastic syndromes. Haematologica. 1998;83:1104-1115. (Pubitemid 29065929)
10. Scott BL, Wells DA, Loken MR, et al. Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome. Blood. 2008;112:2681-2686.
11. Malcovati L, Della Porta MG, Lunghi M, et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia. 2005;19:776-783. (Pubitemid 40663097)
12. Kussick SJ, Wood BL. Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med. 2003;127:1140-1147.
13. Kussick SJ, Wood BL. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the work-up of non-CML myeloproliferative disorders. Am J Clin Pathol. 2003;120:854-865.
14. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci. 1993;677:265-280.
15. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
16. Kroft SH, Karandikar NJ. Flow cytometric analysis of acute leukemias, myelodysplastic syndromes, and myeloproliferative disorders. In: Carey JL, McCoy JP, Keren DF, eds. Flow Cytometry in Clinical Diagnosis. 4th ed. Chicago, IL: American Society for Clinical Pathology; 2007.
17. Harrington AM, Olteanu H, Kroft SH. A dissection of the CD45/side scatter (SS) blast gate in non-acute myeloid disorders and non-neoplastic bone marrows [abstract]. Mod Pathol. 2010;23:301A. Abstract 1345.
18. Murugesan G, Aboudola S, Szpurka H, et al. Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. Am J Clin Pathol. 2006;125:625-633.
19. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
20. Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
21. Wood BL. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med. 2007;27:551-575. (Pubitemid 47078985)
22. McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498-2507.
23. Xu Y, McKenna RW, Karandikar NJ, et al. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol. 2005;124:799-806.
24. Consuelo del Canizo M, Fernandez E, Lopez A, et al. Immunophenotypic analysis of myelodysplastic syndromes. Haematologica. 2003;88:402-407.
25. dim in myelodysplasia. Cytometry B Clin Cytom. 2006;70:63-70.
26. Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res. 2007;31:727-736.
27. Stetler-Stevenson M. Flow cytometric immunophenotyping: emerging as an important diagnostic tool in the evaluation of cytopenic patients [editorial]. Leuk Res. 2009;33:1020-1021.
28. Stetler-Stevenson M, Yuan CM. Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis. Int J Lab Hematol. 2009;31:479-483.